Finance

Beta
Lists
CTX:WSE
Captor Therapeutics SA
PLN 76.80
-0.52%
(-0.40) 1D
Jun 11, 10:58:19 AM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
PLN 77.10
High
PLN 77.10
Low
PLN 76.10
Mkt. cap
488.58M
Avg. vol.
3.25K
Volume
461.00
52-wk high
PLN 89.20
52-wk low
PLN 31.50
EPS
-PLN 7.71
Shares outstanding
6.35M
No. of employees
82
Open
PLN 77.10
High
PLN 77.10
Low
PLN 76.10
Mkt. cap
488.58M
Avg. vol.
3.25K
Volume
461.00
52-wk high
PLN 89.20
52-wk low
PLN 31.50
EPS
-PLN 7.71
Shares outstanding
6.35M
No. of employees
82
News stories
From sources across the web
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
SectorBiotechnology
Websitecaptortherapeutics.com
Last report
May 27, 2026
Fiscal period
Q1 2026
EPS / Est. (PLN)
- / -
Revenue / Est. (PLN)
328.00K / 500.00K
-34.40%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.01M
-
44.00K
328.00K
Cost of goods sold
2.59M
-2.02M
-
-
Cost of revenue
2.59M
-2.02M
-
-
Research and development expenses
10.19M
14.74M
9.82M
10.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.35M
1.37M
2.53M
1.92M
Operating expense
10.16M
13.83M
10.40M
11.59M
Total operating expenses
12.76M
11.81M
10.40M
11.59M
Operating income
-10.74M
-11.81M
-10.36M
-11.26M
Other non operating income
-
1.00K
-8.00K
-
EBT including unusual items
-9.76M
-11.48M
-10.05M
-11.35M
EBT excluding unusual items
-9.76M
-11.48M
-10.12M
-11.35M
Income tax expense
-
-
-
27.00K
Effective tax rate
-
-
-
-0.24%
Other operating expenses
-4.38M
-2.27M
-1.94M
-893.00K
Net income
-9.76M
-11.48M
-10.05M
-11.38M
Net profit margin
-485.32%
-
-22,831.82%
-3,467.99%
Earnings per share
-
-
-
-
Interest and investment income
847.00K
391.00K
303.00K
39.00K
Interest expense
-36.00K
-61.00K
-75.00K
-67.00K
Net interest expenses
811.00K
330.00K
228.00K
-28.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.43M
-10.81M
-9.53M
-10.36M
Gain or loss from assets sale
682.00K
-682.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer